nodes	percent_of_prediction	percent_of_DWPC	metapath
Saprisartan—AGTR1—Peptide ligand-binding receptors—MC2R—prostate cancer	0.0112	0.0112	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—CXCL12—prostate cancer	0.0111	0.0111	CbGpPWpGaD
Saprisartan—AGTR1—GPCRs, Class A Rhodopsin-like—GRPR—prostate cancer	0.0106	0.0106	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—CASP9—prostate cancer	0.0105	0.0105	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—RLN2—prostate cancer	0.0104	0.0104	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—PENK—prostate cancer	0.00995	0.00995	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—GRPR—prostate cancer	0.00912	0.00912	CbGpPWpGaD
Saprisartan—AGTR1—Arf6 trafficking events—INS—prostate cancer	0.00898	0.00898	CbGpPWpGaD
Saprisartan—AGTR1—GPCRs, Class A Rhodopsin-like—MC2R—prostate cancer	0.00874	0.00874	CbGpPWpGaD
Saprisartan—AGTR1—Arf6 trafficking events—CDH1—prostate cancer	0.00873	0.00873	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—GNRH1—prostate cancer	0.00857	0.00857	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—IL10—prostate cancer	0.00843	0.00843	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—LPAR1—prostate cancer	0.0083	0.0083	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—GRP—prostate cancer	0.0083	0.0083	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—PLCB2—prostate cancer	0.00821	0.00821	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—GRP—prostate cancer	0.00819	0.00819	CbGpPWpGaD
Saprisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MMP2—prostate cancer	0.008	0.008	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—CX3CL1—prostate cancer	0.00795	0.00795	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—RLN2—prostate cancer	0.00789	0.00789	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—FASLG—prostate cancer	0.00784	0.00784	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—prostate cancer	0.00766	0.00766	CbGpPWpGaD
Saprisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—FGF2—prostate cancer	0.0076	0.0076	CbGpPWpGaD
Saprisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NOS3—prostate cancer	0.00749	0.00749	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—MC2R—prostate cancer	0.00749	0.00749	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—GNG5—prostate cancer	0.00745	0.00745	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—LPAR1—prostate cancer	0.00742	0.00742	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GRP—prostate cancer	0.00742	0.00742	CbGpPWpGaD
Saprisartan—AGTR1—Arf6 signaling events—SRC—prostate cancer	0.00737	0.00737	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PLCB2—prostate cancer	0.00735	0.00735	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—GRPR—prostate cancer	0.00694	0.00694	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—PENK—prostate cancer	0.00667	0.00667	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNG5—prostate cancer	0.00667	0.00667	CbGpPWpGaD
Saprisartan—AGTR1—Arf6 signaling events—EGFR—prostate cancer	0.00646	0.00646	CbGpPWpGaD
Saprisartan—AGTR1—Arf6 trafficking events—CTNNB1—prostate cancer	0.00644	0.00644	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—ANXA1—prostate cancer	0.0061	0.0061	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—ANXA1—prostate cancer	0.00603	0.00603	CbGpPWpGaD
Saprisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—CDKN1A—prostate cancer	0.00599	0.00599	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—WNT4—prostate cancer	0.00598	0.00598	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—OR51E2—prostate cancer	0.00588	0.00588	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—MC2R—prostate cancer	0.0057	0.0057	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—GNRH1—prostate cancer	0.00567	0.00567	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—CXCL12—prostate cancer	0.00551	0.00551	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—GRP—prostate cancer	0.00549	0.00549	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—LPAR1—prostate cancer	0.00549	0.00549	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—prostate cancer	0.00546	0.00546	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—OR51E2—prostate cancer	0.00534	0.00534	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CX3CL1—prostate cancer	0.00533	0.00533	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—PRKCQ—prostate cancer	0.00509	0.00509	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—PENK—prostate cancer	0.00508	0.00508	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—RGS17—prostate cancer	0.005	0.005	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—CXCL8—prostate cancer	0.00461	0.00461	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCQ—prostate cancer	0.00456	0.00456	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—RGS17—prostate cancer	0.00454	0.00454	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—ITPR1—prostate cancer	0.00453	0.00453	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—RLN2—prostate cancer	0.00446	0.00446	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—CASP3—prostate cancer	0.00441	0.00441	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—IL2—prostate cancer	0.0044	0.0044	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—GNRH1—prostate cancer	0.00432	0.00432	CbGpPWpGaD
Saprisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—prostate cancer	0.00422	0.00422	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—GRP—prostate cancer	0.00418	0.00418	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—LPAR1—prostate cancer	0.00418	0.00418	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—PLXNB1—prostate cancer	0.00408	0.00408	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CX3CL1—prostate cancer	0.00406	0.00406	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR1—prostate cancer	0.00405	0.00405	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—RLN2—prostate cancer	0.00405	0.00405	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ANXA1—prostate cancer	0.00404	0.00404	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—GRPR—prostate cancer	0.00392	0.00392	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—GNG5—prostate cancer	0.00376	0.00376	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—VEGFA—prostate cancer	0.00374	0.00374	CbGpPWpGaD
Saprisartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB2—prostate cancer	0.0037	0.0037	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PLXNB1—prostate cancer	0.0037	0.0037	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—prostate cancer	0.0037	0.0037	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—GRPR—prostate cancer	0.00356	0.00356	CbGpPWpGaD
Saprisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—prostate cancer	0.00344	0.00344	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—TGFB1—prostate cancer	0.00344	0.00344	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—PTHLH—prostate cancer	0.00327	0.00327	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—MC2R—prostate cancer	0.00322	0.00322	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—prostate cancer	0.00317	0.00317	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—OR51E2—prostate cancer	0.00315	0.00315	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—ANXA1—prostate cancer	0.00308	0.00308	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—WNT4—prostate cancer	0.00307	0.00307	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—MC2R—prostate cancer	0.00293	0.00293	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—BMPR1B—prostate cancer	0.00288	0.00288	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CALCA—prostate cancer	0.00288	0.00288	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—PENK—prostate cancer	0.00287	0.00287	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CXCL12—prostate cancer	0.00282	0.00282	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—RGS17—prostate cancer	0.00268	0.00268	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PENK—prostate cancer	0.00261	0.00261	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K1—prostate cancer	0.00249	0.00249	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—GNRH1—prostate cancer	0.00244	0.00244	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—VIP—prostate cancer	0.00244	0.00244	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—ADRB2—prostate cancer	0.00242	0.00242	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—RLN2—prostate cancer	0.00239	0.00239	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—LPAR1—prostate cancer	0.00236	0.00236	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—GRP—prostate cancer	0.00236	0.00236	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—PLCB2—prostate cancer	0.00234	0.00234	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—CXCL8—prostate cancer	0.00228	0.00228	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—HSD17B1—prostate cancer	0.00228	0.00228	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CTBP2—prostate cancer	0.00228	0.00228	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—prostate cancer	0.00227	0.00227	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—PDE4D—prostate cancer	0.00223	0.00223	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—VIP—prostate cancer	0.00222	0.00222	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—GNRH1—prostate cancer	0.00222	0.00222	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PLXNB1—prostate cancer	0.00219	0.00219	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—GRP—prostate cancer	0.00215	0.00215	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—LPAR1—prostate cancer	0.00215	0.00215	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PLCB2—prostate cancer	0.00213	0.00213	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—GNG5—prostate cancer	0.00212	0.00212	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—GRPR—prostate cancer	0.0021	0.0021	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CX3CL1—prostate cancer	0.00208	0.00208	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—IL17RD—prostate cancer	0.00203	0.00203	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PDE4D—prostate cancer	0.00203	0.00203	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—GNG5—prostate cancer	0.00193	0.00193	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—PTHLH—prostate cancer	0.00185	0.00185	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—JUP—prostate cancer	0.00181	0.00181	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—WNT4—prostate cancer	0.00181	0.00181	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—ANXA1—prostate cancer	0.00174	0.00174	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—MC2R—prostate cancer	0.00173	0.00173	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—RALBP1—prostate cancer	0.00173	0.00173	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PTHLH—prostate cancer	0.00168	0.00168	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PRKACB—prostate cancer	0.00164	0.00164	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CALCA—prostate cancer	0.00163	0.00163	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PPP3CA—prostate cancer	0.0016	0.0016	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CXCL12—prostate cancer	0.00159	0.00159	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—ANXA1—prostate cancer	0.00158	0.00158	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PENK—prostate cancer	0.00154	0.00154	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	0.00153	0.00153	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—prostate cancer	0.00151	0.00151	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CALCA—prostate cancer	0.00148	0.00148	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—GHR—prostate cancer	0.00147	0.00147	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—PIK3CA—prostate cancer	0.00147	0.00147	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—PRKCQ—prostate cancer	0.00145	0.00145	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CXCL12—prostate cancer	0.00144	0.00144	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—prostate cancer	0.00143	0.00143	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—NRP1—prostate cancer	0.00141	0.00141	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—ADRB2—prostate cancer	0.00137	0.00137	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—VAV3—prostate cancer	0.00133	0.00133	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PRKCQ—prostate cancer	0.00132	0.00132	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—prostate cancer	0.00131	0.00131	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—GNRH1—prostate cancer	0.00131	0.00131	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—VIP—prostate cancer	0.00131	0.00131	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—ITPR1—prostate cancer	0.00129	0.00129	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—LPAR1—prostate cancer	0.00127	0.00127	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—GRP—prostate cancer	0.00127	0.00127	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PLCB2—prostate cancer	0.00126	0.00126	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—LRP2—prostate cancer	0.00126	0.00126	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—ADRB2—prostate cancer	0.00124	0.00124	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CX3CL1—prostate cancer	0.00123	0.00123	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—P4HB—prostate cancer	0.00123	0.00123	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—VAV3—prostate cancer	0.00121	0.00121	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—HIST1H2BG—prostate cancer	0.00121	0.00121	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PDE4D—prostate cancer	0.0012	0.0012	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—GRB7—prostate cancer	0.0012	0.0012	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—ITPR1—prostate cancer	0.00117	0.00117	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—HIST1H4H—prostate cancer	0.00117	0.00117	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CXCL8—prostate cancer	0.00117	0.00117	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	0.00116	0.00116	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—GNG5—prostate cancer	0.00114	0.00114	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PTHLH—prostate cancer	0.000993	0.000993	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—TGFBR1—prostate cancer	0.000993	0.000993	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—AKR1C3—prostate cancer	0.000977	0.000977	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PRKACB—prostate cancer	0.000971	0.000971	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PPP3CA—prostate cancer	0.000947	0.000947	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—THBS1—prostate cancer	0.000947	0.000947	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—ANXA1—prostate cancer	0.000933	0.000933	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PRKCZ—prostate cancer	0.000916	0.000916	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—PIK3CG—prostate cancer	0.000895	0.000895	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—FGFR4—prostate cancer	0.000885	0.000885	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PARP1—prostate cancer	0.000885	0.000885	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CALCA—prostate cancer	0.000874	0.000874	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CXCL12—prostate cancer	0.000854	0.000854	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PIK3CG—prostate cancer	0.000813	0.000813	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CASP9—prostate cancer	0.000804	0.000804	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—PIK3CD—prostate cancer	0.000787	0.000787	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PRKCQ—prostate cancer	0.000779	0.000779	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—NGFR—prostate cancer	0.000779	0.000779	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—MAP3K7—prostate cancer	0.00077	0.00077	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—FGF10—prostate cancer	0.00074	0.00074	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—ADRB2—prostate cancer	0.000732	0.000732	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—JAK2—prostate cancer	0.000722	0.000722	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—MAP2K1—prostate cancer	0.00072	0.00072	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PIK3CD—prostate cancer	0.000715	0.000715	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—VAV3—prostate cancer	0.000714	0.000714	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—TGFBR2—prostate cancer	0.000704	0.000704	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—ITPR1—prostate cancer	0.000693	0.000693	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—PIK3CB—prostate cancer	0.000686	0.000686	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—IGF1R—prostate cancer	0.000662	0.000662	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CXCL8—prostate cancer	0.000659	0.000659	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—JAK2—prostate cancer	0.000656	0.000656	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—LPL—prostate cancer	0.000635	0.000635	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—IL2—prostate cancer	0.00063	0.00063	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PDGFRB—prostate cancer	0.000629	0.000629	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PIK3CB—prostate cancer	0.000623	0.000623	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—ITGB3—prostate cancer	0.000613	0.000613	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CXCL8—prostate cancer	0.000599	0.000599	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—ERBB3—prostate cancer	0.000595	0.000595	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—FGFR2—prostate cancer	0.000594	0.000594	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—IL2—prostate cancer	0.000572	0.000572	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—TERT—prostate cancer	0.00057	0.00057	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—HIF1A—prostate cancer	0.000545	0.000545	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—LEP—prostate cancer	0.000532	0.000532	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CAV1—prostate cancer	0.000527	0.000527	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—KDR—prostate cancer	0.000521	0.000521	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—ESR1—prostate cancer	0.000508	0.000508	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—BAD—prostate cancer	0.000496	0.000496	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PIK3CG—prostate cancer	0.00048	0.00048	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—APC—prostate cancer	0.00048	0.00048	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—IRS1—prostate cancer	0.000475	0.000475	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—EGF—prostate cancer	0.000475	0.000475	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—GSK3B—prostate cancer	0.000461	0.000461	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—INS—prostate cancer	0.000455	0.000455	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CREBBP—prostate cancer	0.000445	0.000445	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—IGF1—prostate cancer	0.00044	0.00044	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—EGFR—prostate cancer	0.000438	0.000438	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—MAP2K1—prostate cancer	0.000425	0.000425	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PIK3CD—prostate cancer	0.000422	0.000422	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—PIK3CA—prostate cancer	0.000418	0.000418	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—SERPINE1—prostate cancer	0.000418	0.000418	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—KRAS—prostate cancer	0.000413	0.000413	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—FGF2—prostate cancer	0.000404	0.000404	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—NOS3—prostate cancer	0.000399	0.000399	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—JAK2—prostate cancer	0.000388	0.000388	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PIK3CA—prostate cancer	0.00038	0.00038	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—MDM2—prostate cancer	0.000378	0.000378	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—ERBB2—prostate cancer	0.000373	0.000373	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PIK3CB—prostate cancer	0.000368	0.000368	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CXCL8—prostate cancer	0.000354	0.000354	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CDKN1B—prostate cancer	0.000345	0.000345	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—AKT1—prostate cancer	0.000342	0.000342	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CASP3—prostate cancer	0.000339	0.000339	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—IL2—prostate cancer	0.000338	0.000338	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—IL6—prostate cancer	0.000336	0.000336	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CCND1—prostate cancer	0.00033	0.00033	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CTNNB1—prostate cancer	0.000326	0.000326	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—MMP9—prostate cancer	0.00032	0.00032	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CDKN1A—prostate cancer	0.000319	0.000319	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PTEN—prostate cancer	0.000318	0.000318	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—AKT1—prostate cancer	0.00031	0.00031	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—EP300—prostate cancer	0.000303	0.000303	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—SRC—prostate cancer	0.000295	0.000295	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—VEGFA—prostate cancer	0.000287	0.000287	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—STAT3—prostate cancer	0.000284	0.000284	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—MYC—prostate cancer	0.000264	0.000264	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—TGFB1—prostate cancer	0.000264	0.000264	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—EGFR—prostate cancer	0.000259	0.000259	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—KRAS—prostate cancer	0.000244	0.000244	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PIK3CA—prostate cancer	0.000224	0.000224	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—TP53—prostate cancer	0.000217	0.000217	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—IL6—prostate cancer	0.000199	0.000199	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—AKT1—prostate cancer	0.000183	0.000183	CbGpPWpGaD
